HARVARD BIOSCIENCE INC — Director's Dealing 2024

May 23, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2024-05-21

Reporting Person: Eade Katherine A. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-21	Common Stock	A	45872	$0.00	Acquired	311126	Direct

Footnotes

F1: Represents an award of 45,872 restricted stock units that fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 14, 2024, immediately prior to the commencement of such meeting, and (ii) May 21, 2025.

F2: Includes (a) the award described in footnote (1) above and (b) 265,254 shares of common stock held by the Reporting Person.